Literature DB >> 193392

Anti-"i" antibody and hemolytic anemia associated with spontaneous cytomegalovirus mononucleosis.

B S Berlin, R Chandler, D Green.   

Abstract

Hemolytic anemia occurred in a 23-year-old woman with spontaneous cytomegalovirus mononucleosis who had not received a blood transfusion. The patient's serum gave positive reactions in Coombs' antiglobulin test with human cord erythrocytes but did not react with adult "O" cells. Complement-fixation antibody titers against cytomegalovirus and levels of activity against cord erythrocytes increased as the anemia worsened and remained at high levels when recovery from the anemia occurred.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193392     DOI: 10.1093/ajcp/67.5.459

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Severe haemolytic anaemia due to cold anti-'i' antibodies associated with cytomegalovirus infection.

Authors:  J M Aguado; J M Castrillo; J Sanz; J Serrano
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

2.  Coombs-negative severe haemolytic anaemia in an immunocompetent adult following cytomegalovirus infection.

Authors:  W Veldhuis; M Janssen; W Kortlandt; A van Houte; M van de Ree
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-20       Impact factor: 3.267

3.  Cryoglobulinemia: a complication of infectious disease.

Authors:  O Witzke; J Kassubek; E Bonmann; E Musch
Journal:  Clin Investig       Date:  1994-12

Review 4.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

5.  Positive Direct Antiglobulin Test in COVID-19 patients: decision-making process.

Authors:  Julien Cabo; Alice Brochier; Pascale Saussoy; Marie-Astrid van Dievoet; Lena Capirchio; Bénédicte Delire; Véronique Deneys
Journal:  Transfus Clin Biol       Date:  2021-06-07       Impact factor: 1.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.